Arkolith/Insider Trading/RIGL/Form 4

Furey Raymond J.

EVP, GC, CCO & Corp SecRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Feb 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2026Grant(A)19K—$052K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000956) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML